-
Macroeconomic Analysis
NewBelgium PESTLE Insights – A Macroeconomic Outlook Report
Belgium PESTLE Outlook Report Overview The GDP of Belgium was $626.0 billion in 2023 and the country ranked 14th out of 153 nations in the GCRI Q1 2024. The Belgian government introduced the NEED project during its presidency of the Council of the European Union in 2024. During its presidency, Belgium aims to advance its unique multi-criteria approach to categorize unmet medical needs. Buy the Full Report to Get More Insights into the Belgium PESTLE Insights Report Download a Free...
-
Sector Analysis
NewCzech Republic Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Czech Republic Construction Market Report Overview The Czech Republic construction market size was $60.5 billion in 2023. The market is projected to achieve an AAGR of more than 3% during 2025-2028. The following are some of the key highlights of the Czech Republic construction market: The growth of the market is attributed to investment in the transport, housing & energy sectors. Infrastructure construction was the leading revenue-generating Czech Republican construction market sector. Rising railway and airport expansion projects in the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sotagliflozin in Hypertrophic Cardiomyopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sotagliflozin in Hypertrophic Cardiomyopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sotagliflozin in Hypertrophic Cardiomyopathy Drug Details: Sotagliflozin (Zynquista, Inpefa) is a...
-
Sector Analysis
NewNetherlands Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Netherlands Construction Market Overview The Netherlands' construction market size was $174.5 billion in 2023. The market is projected to achieve an AAGR of more than 2% during 2025-2028. Investments in transport and renewable energy infrastructure projects will drive market growth during the forecast period. Netherlands Construction Market Outlook, 2023-2028 ($ Billion) Buy Full Report to Know More about the Netherlands Construction Market Forecast Download a Free Report Sample The Netherlands construction market report has compiled data on various project types...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tirzepatide in Obstructive Sleep Apnea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tirzepatide in Obstructive Sleep Apnea report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tirzepatide in Obstructive Sleep Apnea Drug Details: Tirzepatide (Mounjaro, Zepbound,...
-
Sector Analysis
NewNorth America Destination Tourism Trends Insight by Type, Source Markets, Foreign Direct Investment and Future Opportunities, 2024 Update
North America Destination Tourism Report Overview In 2023, international arrivals to the region reached 126.7 million, which is still lower than the pre-pandemic level seen in 2019. The numbers are however expected to surpass the pre-pandemic levels in 2024. As per GlobalData, the number of international arrivals will grow at a CAGR of more than 8% from 2023 to 2028, helped by the region’s reputation for attractive and varied landscapes, wildlife, sun and beach destinations, modern cities, and appeal for...
-
Macroeconomic Analysis
Norway PESTLE Insights – A Macroeconomic Outlook Report
Norway PESTLE Outlook Report Overview The GDP of Norway was $524.7 billion in 2023 and the country ranked 27th out of 153 nations in the GCRI Q3 2023. The Norwegian government has tasked the Water Resources and Energy Directorate (NVE) with conducting strategic impact assessments for three potential offshore wind areas slated for tendering in 2025. Additionally, NVE will begin assessments for other relevant offshore wind areas towards the country's goal of having 30GW of offshore wind operational by 2040,...
-
Macroeconomic Analysis
Australia PESTLE Insights – A Macroeconomic Outlook Report
Australia PESTLE Outlook Report Overview The GDP of Australia was estimated to be $1.7 trillion in 2023 and the country ranked 19th out of 153 nations in the GCRI Q3 2023. On March 7, 2024, Prime Minister Anthony Albanese declared that Australia is upgrading its relationship with Vietnam to the status of a comprehensive strategic partnership, which will entail an annual discussion on minerals. The advancing bilateral relations would establish Australia and Vietnam as important partners to each other. Buy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tirzepatide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tirzepatide in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tirzepatide in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: Tirzepatide...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Wegovy in Diastolic Heart Failure (HFpEF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Wegovy in Diastolic Heart Failure (HFpEF) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Wegovy in Diastolic Heart Failure (HFpEF) Drug Details: Semaglutide...